Switch to:
GuruFocus has detected 5 Warning Signs with Sanofi SA $SNY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Sanofi SA (NYSE:SNY)
Research & Development
$5,456 Mil (TTM As of Dec. 2016)

This is the expense the company spent on research and development. Sanofi SA's research and development for the six months ended in Dec. 2016 was $2,804 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2016 was $5,456 Mil.


Definition

This is the expense the company spent on research and development.

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sanofi SA Research & Development for the trailing twelve months (TTM) ended in Dec. 2016 was $5,456 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Sanofi SA Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Research & Development 6,6046,1826,6816,0156,3006,4376,3085,7555,5365,456

Sanofi SA Semi-Annual Data

Jun12Dec12Jun13Dec13Jun14Dec14Jun15Dec15Jun16Dec16
Research & Development 3,0203,2783,0903,1003,1622,8852,6992,9162,8252,804
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK